Mu-receptor specificity of the opioid peptide irreversible reagent, [3H] DALECK

E. L. Newman, A. Borsodi, G. Toth, F. Hepp, E. A. Barnard

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

A novel affinity reagent DALECK, i.e. D-Ala2-Leu5-enkephalin with a C-terminal chloromethyl ketone group, was previously synthesized in normal and in tritiated form and shown to react irreversibly at opioid receptors, with some evidence for selectivity for the μ subtype. DALECK tritiated in its phenolic group has been synthesized at 13-fold higher specific radioactivity than in the previous study. In the irreversible reaction of this product at pH 8.1 with rat brain membranes it was confirmed that only one polypeptide there is labelled, of apparent Mr 58,000. Competition between this reaction and ligands highly selective for the μ, δ or κ binding sites yielded curves demonstrating the very high selectivity of the DALECK irreversible reaction for the μ site. The results provide evidence that the μ opioid receptor protein contains only one type of binding subunit, whose apparent Mr is 58,000, this size being dependent upon the conditions used in the gel electrophoresis and being higher when stringent conditions which would reduce all internal disulphide bonds are applied.

Original languageEnglish
Pages (from-to)305-315
Number of pages11
JournalNeuropeptides
Volume8
Issue number4
DOIs
Publication statusPublished - 1986

Fingerprint

Opioid Peptides
mu Opioid Receptor
Opioid Receptors
Enkephalins
Radioactivity
Ketones
Electrophoresis
Disulfides
Rats
Brain
Gels
Binding Sites
Ligands
Membranes
Peptides
tyrosyl-alanyl-glycyl-phenylalanyl-leucine chloromethyl ketone
Proteins

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Clinical Neurology
  • Neuroscience(all)
  • Cellular and Molecular Neuroscience

Cite this

Mu-receptor specificity of the opioid peptide irreversible reagent, [3H] DALECK. / Newman, E. L.; Borsodi, A.; Toth, G.; Hepp, F.; Barnard, E. A.

In: Neuropeptides, Vol. 8, No. 4, 1986, p. 305-315.

Research output: Contribution to journalArticle

Newman, E. L. ; Borsodi, A. ; Toth, G. ; Hepp, F. ; Barnard, E. A. / Mu-receptor specificity of the opioid peptide irreversible reagent, [3H] DALECK. In: Neuropeptides. 1986 ; Vol. 8, No. 4. pp. 305-315.
@article{a1462222e3224bc4a4d3831a872c47ea,
title = "Mu-receptor specificity of the opioid peptide irreversible reagent, [3H] DALECK",
abstract = "A novel affinity reagent DALECK, i.e. D-Ala2-Leu5-enkephalin with a C-terminal chloromethyl ketone group, was previously synthesized in normal and in tritiated form and shown to react irreversibly at opioid receptors, with some evidence for selectivity for the μ subtype. DALECK tritiated in its phenolic group has been synthesized at 13-fold higher specific radioactivity than in the previous study. In the irreversible reaction of this product at pH 8.1 with rat brain membranes it was confirmed that only one polypeptide there is labelled, of apparent Mr 58,000. Competition between this reaction and ligands highly selective for the μ, δ or κ binding sites yielded curves demonstrating the very high selectivity of the DALECK irreversible reaction for the μ site. The results provide evidence that the μ opioid receptor protein contains only one type of binding subunit, whose apparent Mr is 58,000, this size being dependent upon the conditions used in the gel electrophoresis and being higher when stringent conditions which would reduce all internal disulphide bonds are applied.",
author = "Newman, {E. L.} and A. Borsodi and G. Toth and F. Hepp and Barnard, {E. A.}",
year = "1986",
doi = "10.1016/0143-4179(86)90002-8",
language = "English",
volume = "8",
pages = "305--315",
journal = "Neuropeptides",
issn = "0143-4179",
publisher = "Churchill Livingstone",
number = "4",

}

TY - JOUR

T1 - Mu-receptor specificity of the opioid peptide irreversible reagent, [3H] DALECK

AU - Newman, E. L.

AU - Borsodi, A.

AU - Toth, G.

AU - Hepp, F.

AU - Barnard, E. A.

PY - 1986

Y1 - 1986

N2 - A novel affinity reagent DALECK, i.e. D-Ala2-Leu5-enkephalin with a C-terminal chloromethyl ketone group, was previously synthesized in normal and in tritiated form and shown to react irreversibly at opioid receptors, with some evidence for selectivity for the μ subtype. DALECK tritiated in its phenolic group has been synthesized at 13-fold higher specific radioactivity than in the previous study. In the irreversible reaction of this product at pH 8.1 with rat brain membranes it was confirmed that only one polypeptide there is labelled, of apparent Mr 58,000. Competition between this reaction and ligands highly selective for the μ, δ or κ binding sites yielded curves demonstrating the very high selectivity of the DALECK irreversible reaction for the μ site. The results provide evidence that the μ opioid receptor protein contains only one type of binding subunit, whose apparent Mr is 58,000, this size being dependent upon the conditions used in the gel electrophoresis and being higher when stringent conditions which would reduce all internal disulphide bonds are applied.

AB - A novel affinity reagent DALECK, i.e. D-Ala2-Leu5-enkephalin with a C-terminal chloromethyl ketone group, was previously synthesized in normal and in tritiated form and shown to react irreversibly at opioid receptors, with some evidence for selectivity for the μ subtype. DALECK tritiated in its phenolic group has been synthesized at 13-fold higher specific radioactivity than in the previous study. In the irreversible reaction of this product at pH 8.1 with rat brain membranes it was confirmed that only one polypeptide there is labelled, of apparent Mr 58,000. Competition between this reaction and ligands highly selective for the μ, δ or κ binding sites yielded curves demonstrating the very high selectivity of the DALECK irreversible reaction for the μ site. The results provide evidence that the μ opioid receptor protein contains only one type of binding subunit, whose apparent Mr is 58,000, this size being dependent upon the conditions used in the gel electrophoresis and being higher when stringent conditions which would reduce all internal disulphide bonds are applied.

UR - http://www.scopus.com/inward/record.url?scp=0022854092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022854092&partnerID=8YFLogxK

U2 - 10.1016/0143-4179(86)90002-8

DO - 10.1016/0143-4179(86)90002-8

M3 - Article

C2 - 3029618

AN - SCOPUS:0022854092

VL - 8

SP - 305

EP - 315

JO - Neuropeptides

JF - Neuropeptides

SN - 0143-4179

IS - 4

ER -